Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18599692 | MULTIPATH REPEATER SYSTEMS | March 2024 | March 2025 | Abandon | 13 | 1 | 0 | No | No |
| 18136051 | DEDICATED CORE NETWORKS (DCN) SELECTION | April 2023 | January 2025 | Abandon | 21 | 2 | 0 | No | No |
| 18126991 | REMEDIATING ANOMALIES IN A SELF-HEALING NETWORK | March 2023 | May 2025 | Allow | 26 | 0 | 0 | No | No |
| 17826578 | Deactivation Timer for a Secondary Cell with a Control Channel | May 2022 | November 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17480708 | APPARATUS FOR TRANSMITTING SIGNALING INFORMATION, APPARATUS FOR RECEIVING SIGNALING INFORMATION, METHOD FOR TRANSMITTING SIGNALING INFORMATION AND METHOD FOR RECEIVING SIGNALING INFORMATION | September 2021 | June 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17373067 | SAMPLE MEASUREMENT TOA CORRECTION | July 2021 | March 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17155211 | METHOD AND SYSTEM FOR SATELLITE DOWNLINK PROPAGATION PREDICTION | January 2021 | January 2025 | Abandon | 47 | 4 | 0 | No | No |
| 17144949 | PACKET CONTROL METHOD AND NODE DEVICE | January 2021 | April 2024 | Abandon | 39 | 4 | 0 | No | No |
| 16635014 | METHOD FOR PERFORMING INITIAL ACCESS IN WIRELESS COMMUNICATION SYSTEM AND APPARATUS THEREFOR | January 2020 | June 2021 | Allow | 16 | 3 | 0 | No | No |
| 16338749 | Controlling Validity Time of Uplink Grant in Target Cell during RACH-Less Handover | April 2019 | June 2022 | Abandon | 38 | 1 | 0 | No | No |
| 11329982 | STEROIDAL COMPOUNDS FOR INHIBITING STEROID SULPHATASE | January 2006 | April 2007 | Allow | 15 | 2 | 0 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner AVELLINO, JOSEPH E works in Art Unit 2478 and has examined 10 patent applications in our dataset. With an allowance rate of 30.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.
Examiner AVELLINO, JOSEPH E's allowance rate of 30.0% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by AVELLINO, JOSEPH E receive 2.00 office actions before reaching final disposition. This places the examiner in the 65% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by AVELLINO, JOSEPH E is 33 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
When applicants file an RCE with this examiner, 0.0% of applications are subsequently allowed. This success rate is in the 0% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 41% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 2% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 10.0% of allowed cases (in the 96% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 19% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.